These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20071669)

  • 1. The cost of visual impairment: purposes, perspectives, and guidance.
    Frick KD; Kymes SM; Lee PP; Matchar DB; Pezzullo ML; Rein DB; Taylor HR;
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1801-5. PubMed ID: 20071669
    [No Abstract]   [Full Text] [Related]  

  • 2. Costs of interventions for visual impairment.
    Taylor HR; Pezzullo ML; Nesbitt SJ; Keeffe JE
    Am J Ophthalmol; 2007 Apr; 143(4):561-5. PubMed ID: 17222383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of indirect costs for people with vision impairment.
    Chou SL; Misajon R; Gallo J; Keeffe JE
    Clin Exp Ophthalmol; 2003 Aug; 31(4):336-40. PubMed ID: 12880460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personal costs of visual impairment by different eye diseases and severity of visual loss.
    Wong EY; Chou SL; Lamoureux EL; Keeffe JE
    Ophthalmic Epidemiol; 2008; 15(5):339-44. PubMed ID: 18850471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An estimation of the worldwide economic and health burden of visual impairment.
    Gordois A; Cutler H; Pezzullo L; Gordon K; Cruess A; Winyard S; Hamilton W; Chua K
    Glob Public Health; 2012; 7(5):465-81. PubMed ID: 22136197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact and cost of visual impairment in Australia.
    Taylor HR; Pezzullo ML; Keeffe JE
    Br J Ophthalmol; 2006 Mar; 90(3):272-5. PubMed ID: 16488942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost utility for penetrating keratoplasty in patients with poor binocular vision.
    Hirneiss C; Neubauer AS; Niedermeier A; Messmer EM; Ulbig M; Kampik A
    Ophthalmology; 2006 Dec; 113(12):2176-80. PubMed ID: 16996598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Economic Burden of Visual Impairment and Comorbid Fatigue: A Cost-of-Illness Study (From a Societal Perspective).
    Schakel W; van der Aa HPA; Bode C; Hulshof CTJ; van Rens GHMB; van Nispen RMA
    Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1916-1923. PubMed ID: 29677352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 53(3):57-9. PubMed ID: 14749614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Visual impairment -- implications on health, costs and predictions for the future].
    Müller A
    Klin Monbl Augenheilkd; 2005 Jan; 222(1):32-5. PubMed ID: 15678397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for measuring personal costs associated with vision impairment.
    Chou SL; Lamoureux E; Keeffe J
    Ophthalmic Epidemiol; 2006 Dec; 13(6):355-63. PubMed ID: 17169848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical care cost of Medicare/Medicaid beneficiaries with vision loss.
    Morse AR; Pyenson BS
    Ophthalmic Epidemiol; 2009; 16(1):50-7. PubMed ID: 19191182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing visual profile of children attending a regional specialist school for the visually impaired in Northern Ireland.
    McClelland J; Saunders KJ; Hill N; Magee A; Shannon M; Jackson AJ
    Ophthalmic Physiol Opt; 2007 Nov; 27(6):556-60. PubMed ID: 17956360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression in older people: visual impairment and subjective ratings of health.
    Hayman KJ; Kerse NM; La Grow SJ; Wouldes T; Robertson MC; Campbell AJ
    Optom Vis Sci; 2007 Nov; 84(11):1024-30. PubMed ID: 18043421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life of multiple sclerosis in Sweden.
    Berg J; Lindgren P; Fredrikson S; Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vision problems are a leading source of modifiable health expenditures.
    Rein DB
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(14):ORSF18-22. PubMed ID: 24335062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective cost-effectiveness analysis of vertical banded gastroplasty for the treatment of morbid obesity.
    van Gemert WG; Adang EM; Kop M; Vos G; Greve JW; Soeters PB
    Obes Surg; 1999 Oct; 9(5):484-91. PubMed ID: 10605908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.